Trial Profile
Viro-Immunologic Effects of Interrupting Maraviroc in Patients Failing a Maraviroc-containing Antiretroviral Treatment (The Maraviroc Short-Stop Study) [Studio degli effetti immuno-virologici dell'interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc]
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2013
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Abacavir; Atazanavir; Darunavir; Didanosine; Efavirenz; Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Etravirine; Fosamprenavir; Lamivudine; Lamivudine/abacavir; Lamivudine/zidovudine; Lopinavir; Nevirapine; Raltegravir; Ritonavir; Saquinavir; Stavudine; Tenofovir disoproxil fumarate; Tipranavir; Zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms The Maraviroc Short-Stop Study
- 25 Jul 2012 New trial record